Literature DB >> 6125367

A new urinary metabolite of clofazimine in leprosy patients.

P C Feng, C C Fenselau, R R Jacobson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6125367

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN： 0090-9556            Impact factor:   3.922


× No keyword cloud information.
  4 in total

1.  Characterization of Clofazimine Metabolism in Human Liver Microsomal Incubation In Vitro.

Authors:  Saurav Howlader; Min-Jung Kim; M Rasheduzzaman Jony; Nguyen Phuoc Long; Yong-Soon Cho; Dong-Hyun Kim; Jae-Gook Shin
Journal:  Antimicrob Agents Chemother       Date:  2022-10-03       Impact factor: 5.938

2.  Characterization of Clofazimine as a Potential Substrate of Drug Transporter.

Authors:  M Rasheduzzaman Jony; Yong-Soon Cho; Nguyen Phuoc Long; Ho-Jung Shin; Jae-Gook Shin
Journal:  Antimicrob Agents Chemother       Date:  2022-03-07       Impact factor: 5.938

Review 3.  Clinical pharmacokinetic considerations in the treatment of patients with leprosy.

Authors:  K Venkatesan
Journal:  Clin Pharmacokinet       Date:  1989-06       Impact factor: 6.447

Review 4.  Clinical pharmacokinetics of clofazimine. A review.

Authors:  M R Holdiness
Journal:  Clin Pharmacokinet       Date:  1989-02       Impact factor: 6.447
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.